Cumberland Pharmaceuticals Inc. (CPIX) Set to Announce Earnings on Monday
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) is scheduled to release its earnings data after the market closes on Monday, July 31st.
Cumberland Pharmaceuticals (NASDAQ:CPIX) last announced its quarterly earnings results on Monday, May 15th. The specialty pharmaceutical company reported ($0.08) earnings per share for the quarter. Cumberland Pharmaceuticals had a negative net margin of 5.63% and a positive return on equity of 1.93%. The company had revenue of $9.64 million for the quarter. On average, analysts expect Cumberland Pharmaceuticals to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Shares of Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) opened at 7.0101 on Monday. The firm’s 50 day moving average is $6.96 and its 200-day moving average is $6.39. The firm’s market capitalization is $112.39 million. Cumberland Pharmaceuticals Inc. has a 12 month low of $4.40 and a 12 month high of $7.49.
COPYRIGHT VIOLATION NOTICE: “Cumberland Pharmaceuticals Inc. (CPIX) Set to Announce Earnings on Monday” was originally published by American Banking News and is owned by of American Banking News. If you are viewing this report on another website, it was stolen and republished in violation of US and international copyright laws. The legal version of this report can be viewed at https://www.americanbankingnews.com/2017/07/24/cumberland-pharmaceuticals-inc-cpix-set-to-announce-earnings-on-monday.html.
About Cumberland Pharmaceuticals
Cumberland Pharmaceuticals Inc (Cumberland) is a specialty pharmaceutical company. The Company is focused on the acquisition, development and commercialization of branded prescription products. The Company operates through specialty pharmaceutical products segment. The Company’s product portfolio includes Acetadote (acetylcysteine) Injection for the treatment of acetaminophen poisoning; Caldolor (ibuprofen) Injection for the treatment of pain and fever; Kristalose (lactulose) for Oral Solution for the treatment of chronic and acute constipation; Omeclamox-Pak, (omeprazole, clarithromycin, amoxicillin) for the treatment of Helicobacter pylori (H.
Receive News & Ratings for Cumberland Pharmaceuticals Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cumberland Pharmaceuticals Inc. and related companies with MarketBeat.com's FREE daily email newsletter.